Home

Chris Nolet

CIK 1782814 · last filed 2026-06-22

Chris Nolet is a corporate insider who has filed 23 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing, for AVBP, was dated Jun 22, 2026. Current disclosed insider exposure totals $393 across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$393

Companies

5

Total Filings

23

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVBP Director — $29.98 — $0 3 2026-06-22
JSPRW Director 32,500 $0.01 $393 $0 5 2025-07-03
Revance Therapeutics, Inc. (RVNC) Delisted Director 0 $3.65 $0 $0 8 2025-02-06
POLARITYTE, INC. (PTE) Delisted Director 14,403 $0.24 $3.5K $0 4 2023-01-17
Viela Bio, Inc. (VIE) Delisted Director — — — $0 2 2021-03-15

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 AVBP Grant (A) — $0 EDGAR
2025-07-03 JSPRW Grant (A) — $0 EDGAR
2025-06-20 AVBP Grant (A) — $0 EDGAR
2025-02-06 Revance Therapeutics, Inc. (RVNC) Delisted Mixed −43,606 -$104.4K EDGAR
2024-06-10 JSPRW Grant (A) — $0 EDGAR
2024-05-03 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +15,000 $0 EDGAR
2024-01-29 AVBP Grant (A) — $0 EDGAR
2023-06-08 JSPRW Grant (A) — $0 EDGAR
2023-05-05 Revance Therapeutics, Inc. (RVNC) Delisted Grant (A) +3,534 $0 EDGAR
2023-01-17 POLARITYTE, INC. (PTE) Delisted Exer (M) −36,497 $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.